December 19, 2016 — Biodex Medical Systems Inc. recently announced the redesign and availability of the new Surgical C-Arm Table 840.
As minimally invasive surgical options have increased over the past decade — with approximately 9 million such procedures performed in the United States in 2013 — surgeons have come to rely on C-arm fluoroscopy devices for a variety of cardiovascular, orthopedic and urology procedures. The new Surgical C-Arm Table 840 from Biodex is a stable, accessible and vibration-free fluoroscopic table that keeps a patient at exactly the right position and angle for his cardiovascular procedure.
The low-profile base of this radiolucent imaging table from Biodex guarantees C-arm clearance, whether using portable or ceiling-suspended C-arms. It features an extra-large radiolucent area of 71 inches and accommodates patients weighing up to 500 pounds. Proper positioning along three axes is possible with a free-float Smooth Glide tabletop movement of 35 inches head-to-toe and 10 inches side-to-side. High-speed actuators assure quick tabletop positioning, including height adjustability from 33.5 to 43.5 inches, an isocentric lateral roll of 0 degrees to ±15 degrees, and Trendelenburg motions (and reverse motions) of 0 degrees to 20 degrees. Multiple positioning control access is made possible with mushroom-top, hand and foot controls.
The Biodex Surgical C-Arm Table 840 is available with either a contoured or rectangular carbon-fiber tabletop, both with a 2-inch mattress. The contoured tabletop features a face cutout for comfortable prone positioning. A removable, non-radiolucent catheter tray extension provides additional table length to hold catheters within the patient's sterile field. In order to accommodate a variety of settings, the fluoroscopic table comes standard with both AC and battery power options.
The Surgical C-Arm Table 840 was displayed at the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Nov. 27-Dec. 1 in Chicago.
For more information: www.biodex.com
April 23, 2024 
